Note: Ingredients listed on restricted chemical lists
EC/CAS
68909-20-6
Name of the chemical
Silanamine, 1,1,1-trimethyl-N-(trimethylsilyl)-, hydrolysis products with silica
Concentration
N/A
General Information
Revision date
2018-06-11
Product name
CAB-O-SIL TG-C110 Colloidal
Product Synonyms
Silicon Dioxide Synthetic Amorphous Silica
CAS No.
68909-20-6
1.2.1 Relevant identified uses
Various, Rheological control, Flow agent, Tribocharging agent, Thickening agent, Reinforcing agent in:, Inks and toners
1.2.2. Uses advised against
Not known as per REACH joint registration dossier
Icons in SDS
Company Information
company name
Cabot EMEA* Headquarters
e-mail address of the competent person responsible for the Safety Data Sheet
SDS@cabotcorp.com
GHS Information
Signal word
None
Section 2
2.1 Classification of the substance or mixture
Not a hazardous substance according to Regulation (EC) 1272/2008 (CLP), its various amendments and adaptations and Directive 67/548/EEC.
Hazard pictograms
None
Signal word
None
Hazard statements
None
Precautionary statements
None
2.3 Other hazards
Do not expose to temperatures above 150°C. Hazardous products of combustion can include carbon monoxide, carbon dioxide and nitrogen oxides (NOx).
Principle Routes of Exposure
Inhalation, Skin Contact, Eye contact Eye Contact: May cause mechanical irritation. Avoid contact with eyes. Skin Contact: May cause mechanical irritation and skin drying. Avoid contact with skin. No cases of sensitization in humans have been reported. Inhalation: Dust may be irritating to respiratory tract. Provide appropriate exhaust ventilation at machinery and at places where dust can be generated. See also Section 8. Ingestion: Adverse health effects are not expected. See Section 11. Carcinogenicity: Does not contain any substances greater than 0.1% listed by IARC (International Agency for Research on Cancer), NTP (National Toxicology Program), OSHA (Occupational Safety and Health Administration), ACGIH (American Conference for Governmental Industrial Hygienists) or EU (European Union). See also Section 11. Target Organ Effects: Lungs, See Section 11
Medical Conditions Generally Aggravated by Exposure
Asthma, Respiratory disorder Exposure:
Environmental effects
None known. See Section 12.
